Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines (Q37604385)

21 August 2017

1 reference

title

Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines (English)

1 reference

21 August 2017

0 references

Olivier Fardel

1

1 reference

21 August 2017

Marc Le Vée

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

Expert Opinion on Drug Metabolism & Toxicology

21 August 2017

published in

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

12

1 reference

21 August 2017

page(s)

1469-1481

1 reference

Altered theophylline pharmacokinetics during acute respiratory viral illness

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Alteration of drug biotransformation and elimination during infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Regulation of cytochromes P450 during inflammation and infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Regulation of drug-metabolizing enzymes and transporters in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Cytokines in acute and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Transporters as a determinant of drug clearance and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Drug transport proteins in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Regulation of drug transporters during infection and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Regulation of transporters by nuclear hormone receptors: implications during inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Clinical versatility of porcine hepatocytes in the light of interspecies differences in cytochrome P450 regulation and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Expression and regulation of hepatic drug and bile acid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Drug uptake systems in liver and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Bile acid transporters: structure, function, regulation and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

The organic anion transporter (OATP) family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

The complexities of hepatic drug transport: current knowledge and emerging concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

A human transporter protein that mediates the final excretion step for toxic organic cations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

The P-glycoprotein multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

The ATP-binding cassette transporters and their implication in drug disposition: a special look at the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

The bile salt export pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Physiological, pharmacological and clinical features of the multidrug resistance protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

The apical conjugate efflux pump ABCC2 (MRP2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

21 January 2018

ABCG2: a perspective.

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Cytokines Alter the Expression and Activity of the Multidrug Resistance Transporters in Human Hepatoma Cell Lines; Analysis Using RT‐PCR and cDNA Microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Induction of ABCC3 (MRP3) by pregnane X receptor activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Methods to evaluate biliary excretion of drugs in humans: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

P-glycoprotein expression in human, mouse, hamster and rat hepatocytes in primary culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Interleukin-1beta represses MRP2 gene expression through inactivation of interferon regulatory factor 3 in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

A novel role of transforming growth factor beta1 in transcriptional repression of human cholesterol 7alpha-hydroxylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Human hepatocytes: isolation, cryopreservation and applications in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

In vitro-in vivo correlation of hepatobiliary drug clearance in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b Genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Inflammatory mechanisms in the regulation of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Hepatocyte nuclear factor (HNF) 1 and HNF4 mediate hepatic multidrug resistance protein 2 up-regulation during hepatitis C virus gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

An update on metabolism studies using human hepatocytes in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903304056

10.1517/17425250903304056

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference